ArticleProtein science : a publication of the Protein Society2026
Soluble protein analog selection engine (SPASE): An automated AI-powered server to improve protein engineering workflows.
Article in Protein science : a publication of the Protein Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Soluble protein analog selection engine (SPASE): An automated AI-powered server to improve protein engineering workflows.Protein science : a publication of the Protein Society · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The design of proteins with desired biophysical properties, such as high solubility and low aggregation propensity, is crucial for various biotechnological and biomedical applications. While deep learning-based methods like ProteinMPNN have shown remarkable success in protein sequence design, their direct output may not always exhibit optimal solubility and aggregation properties. Here, we present Soluble Protein Analog Selection Engine (SPASE), a novel automated webserver that addresses this challenge by integrating ProteinMPNN with state-of-the-art tools for protein solubility prediction (Protein-Sol) and aggregation prediction (Aggrescan3D). SPASE automatically generates a diverse pool of protein variants using soluble ProteinMPNN, predicts the solubility of each analog, models their three-dimensional structures with ESMFold, and scores these variants based on their predicted solubility, aggregation propensity, and folding confidence. Computational benchmarking indicates that SPASE enriches for protein analogs with higher predicted solubility and lower predicted aggregation propensity than the average output of soluble ProteinMPNN. We discuss the advantages and limitations of the workflow, including challenges associated with protein novelty, solubility prediction, and aggregation assessment. These considerations highlight the value of integrated platforms for prioritizing protein designs across multiple predicted biophysical properties. Together, these results position the SPASE server as a practical and accessible computational platform for prioritizing protein engineering candidates for downstream experimental evaluation. SPASE is publicly available at https://proteinengineering.ca/, which serves as its stable public access portal.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.